Clinical Trial Update: Clinical Evaluation of the Efficacy OF Botulinum Toxin A for Improving Facial Scars [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating the efficacy of Botulinum Toxin A for improving hypertrophic facial scars, currently in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Scarring

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Alexandria University | Conditions: Hypertrophic Scarring | Phase 2, Phase 3 | Status: UNKNOWN